chrX-15358162-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_004469.5(VEGFD):c.333C>T(p.Cys111=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,206,942 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 113 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00033 ( 0 hom. 108 hem. )
Consequence
VEGFD
NM_004469.5 synonymous
NM_004469.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.38
Genes affected
VEGFD (HGNC:3708): (vascular endothelial growth factor D) The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-15358162-G-A is Benign according to our data. Variant chrX-15358162-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2660053.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VEGFD | NM_004469.5 | c.333C>T | p.Cys111= | synonymous_variant | 3/7 | ENST00000297904.4 | |
PIR-FIGF | NR_037859.2 | n.1308C>T | non_coding_transcript_exon_variant | 11/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VEGFD | ENST00000297904.4 | c.333C>T | p.Cys111= | synonymous_variant | 3/7 | 1 | NM_004469.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000134 AC: 15AN: 112087Hom.: 0 Cov.: 22 AF XY: 0.000146 AC XY: 5AN XY: 34233
GnomAD3 genomes
AF:
AC:
15
AN:
112087
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
34233
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000207 AC: 37AN: 178398Hom.: 0 AF XY: 0.000143 AC XY: 9AN XY: 63144
GnomAD3 exomes
AF:
AC:
37
AN:
178398
Hom.:
AF XY:
AC XY:
9
AN XY:
63144
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000331 AC: 362AN: 1094855Hom.: 0 Cov.: 30 AF XY: 0.000300 AC XY: 108AN XY: 360391
GnomAD4 exome
AF:
AC:
362
AN:
1094855
Hom.:
Cov.:
30
AF XY:
AC XY:
108
AN XY:
360391
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000134 AC: 15AN: 112087Hom.: 0 Cov.: 22 AF XY: 0.000146 AC XY: 5AN XY: 34233
GnomAD4 genome
AF:
AC:
15
AN:
112087
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
34233
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | VEGFD: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at